These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2613916)

  • 1. Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis.
    Violi F; Alessandri C; Ferro D; Saliola M; Cordova C; Musca A; Balsano F
    J Clin Pathol; 1989 Dec; 42(12):1246-9. PubMed ID: 2613916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prekallikrein and factor VII as prognostic indexes of liver failure.
    Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Musca A; Balsano F
    Am J Clin Pathol; 1986 May; 85(5):579-82. PubMed ID: 3635353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. CALC Group.
    Violi F; Ferro D; Basili S; Cimminiello C; Saliola M; Vezza E; Cordova C
    Hepatology; 1995 Jul; 22(1):96-100. PubMed ID: 7601439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfibrinolysis in cirrhosis.
    Pises P; Bick R; Siegel B
    Am J Gastroenterol; 1973 Sep; 60(3):280-9. PubMed ID: 4126798
    [No Abstract]   [Full Text] [Related]  

  • 5. 1-year survey of patients with advanced liver cirrhosis. Prognostic value of clinical and laboratory indexes identified by the Cox regression model.
    Ferro D; Saliola M; Quintarelli C; Alessandri C; Basili S; Cordova C; Bonavita MS; Violi F
    Scand J Gastroenterol; 1992 Oct; 27(10):852-6. PubMed ID: 1439538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prekallikrein as a prognostic indicator in chronic liver insufficiency.
    Agnholt J; Mikkelsen JH; i Bud M; Møller-Petersen J; Rasmussen SN; Dyerberg J
    Scand J Gastroenterol; 1990 Jan; 25(1):40-4. PubMed ID: 2154845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfibrinolysis in liver disease.
    Ferro D; Celestini A; Violi F
    Clin Liver Dis; 2009 Feb; 13(1):21-31. PubMed ID: 19150306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.
    Violi F; Ferro D
    Semin Thromb Hemost; 2013 Jun; 39(4):426-33. PubMed ID: 23487343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VII in liver cirrhosis.
    Orlando M; Casalbore P; Camagna A; Lauro R; Tardella L; Hassan HJ
    Haemostasis; 1982; 11(2):73-8. PubMed ID: 7084811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prekallikrein (Fletcher factor) deficiency in clinical disease states.
    Ragni MV; Lewis JH; Hasiba U; Spero JA
    Thromb Res; 1980 Apr 1-15; 18(1-2):45-54. PubMed ID: 6902559
    [No Abstract]   [Full Text] [Related]  

  • 11. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
    Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F
    J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood coagulation system and fibrinolysis in patients with liver cirrhosis].
    Nielubowicz J; Lukasiewicz H
    Pol Przegl Chir; 1970 Oct; 42(10):1391-7. PubMed ID: 5495009
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma prekallikrein, coagulation and fibrinolytic parameters in myeloma patients.
    Annichino-Bizzacchi JM; Sampaio CA
    Nouv Rev Fr Hematol (1978); 1992; 34(2):201-3. PubMed ID: 1502028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma prekallikrein and endotoxemia in liver cirrhosis.
    van Vliet AC; van Vliet HH; Dzoljić-Danilović G; Wilson JH
    Thromb Haemost; 1981 Feb; 45(1):65-7. PubMed ID: 7018004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Initiation of blood coagulation].
    Saito H
    Rinsho Byori; 1985 Sep; 33(9):960-5. PubMed ID: 3878416
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.
    Violl F; Basili S; Ferro D; Quintarelli C; Alessandril C; Cordova C
    Thromb Haemost; 1996 Aug; 76(2):177-83. PubMed ID: 8865526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Saliola M; Alessandri C; Cordova C; Balsano F
    Hepatology; 1992 Apr; 15(4):672-6. PubMed ID: 1551645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis.
    Serra MA; Puchades MJ; Rodríguez F; Escudero A; del Olmo JA; Wassel AH; Rodrigo JM
    Scand J Gastroenterol; 2004 Nov; 39(11):1149-53. PubMed ID: 15545175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fibrinolytic Status in Liver Diseases.
    Leebeek FW; Rijken DC
    Semin Thromb Hemost; 2015 Jul; 41(5):474-80. PubMed ID: 26049070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.